These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recent Updates on Glucokinase Activators and Glucokinase Regulatory Protein Disrupters for the Treatment of Type 2 Diabetes Mellitus. Kaushik A; Kaushik M Curr Diabetes Rev; 2019; 15(3):205-212. PubMed ID: 30039763 [TBL] [Abstract][Full Text] [Related]
5. Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes. Li P; Zhu D J Diabetes; 2024 May; 16(5):e13544. PubMed ID: 38664885 [TBL] [Abstract][Full Text] [Related]
6. Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy. Guertin KR; Grimsby J Curr Med Chem; 2006; 13(15):1839-43. PubMed ID: 16787225 [TBL] [Abstract][Full Text] [Related]
7. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus. Grewal AS; Sekhon BS; Lather V Mini Rev Med Chem; 2014; 14(7):585-602. PubMed ID: 25052034 [TBL] [Abstract][Full Text] [Related]
8. Recent clinical advances of glucokinase activators in the treatment of diabetes mellitus type 2. Li W; Zhang X; Sun Y; Liu Z Pharmazie; 2020 Jun; 75(6):230-235. PubMed ID: 32539915 [TBL] [Abstract][Full Text] [Related]
9. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus. Xu J; Lin S; Myers RW; Addona G; Berger JP; Campbell B; Chen HS; Chen Z; Eiermann GJ; Elowe NH; Farrer BT; Feng W; Fu Q; Kats-Kagan R; Kavana M; Malkani S; McMasters DR; Mitra K; Pachanski MJ; Tong X; Trujillo ME; Xu L; Zhang B; Zhang F; Zhang R; Parmee ER Bioorg Med Chem Lett; 2017 May; 27(9):2069-2073. PubMed ID: 28284804 [TBL] [Abstract][Full Text] [Related]
15. Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Matschinsky FM Diabetes; 2002 Dec; 51 Suppl 3():S394-404. PubMed ID: 12475782 [TBL] [Abstract][Full Text] [Related]
16. Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus. Wang P; Liu H; Chen L; Duan Y; Chen Q; Xi S J Diabetes Res; 2017; 2017():5812607. PubMed ID: 28191470 [TBL] [Abstract][Full Text] [Related]
17. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Matschinsky FM; Magnuson MA; Zelent D; Jetton TL; Doliba N; Han Y; Taub R; Grimsby J Diabetes; 2006 Jan; 55(1):1-12. PubMed ID: 16380470 [TBL] [Abstract][Full Text] [Related]
18. Targeting glucokinase activation for the treatment of type 2 diabetes--a status review. Sarabu R; Grimsby J Curr Opin Drug Discov Devel; 2005 Sep; 8(5):631-7. PubMed ID: 16159025 [TBL] [Abstract][Full Text] [Related]
19. The glucose-6-phosphatase/glucokinase ratio in the liver of obese-diabetic subjects. Belfiore F; Romeo F; Iannello S; Salamone C Biochem Med Metab Biol; 1989 Feb; 41(1):77-80. PubMed ID: 2540781 [TBL] [Abstract][Full Text] [Related]